EffiCacy and safety of topical ketoroLac trOmethamine and sUbtenon triamcinolone acetonideand a “watch-and-wait” strategy for acute pseudophakic macular eDema: a randomized phase-3 trial Beurteilung der Wirksamkeit und Sicherheit von topischem Ketorolac-Trometamol, sub-Tenon Triamcinolonacetonid oder Observanz zur Behandlung des akuten pseudophaken Makulaödems: eine randomisierte Phase-3 Studie

Trial Profile

EffiCacy and safety of topical ketoroLac trOmethamine and sUbtenon triamcinolone acetonideand a “watch-and-wait” strategy for acute pseudophakic macular eDema: a randomized phase-3 trial Beurteilung der Wirksamkeit und Sicherheit von topischem Ketorolac-Trometamol, sub-Tenon Triamcinolonacetonid oder Observanz zur Behandlung des akuten pseudophaken Makulaödems: eine randomisierte Phase-3 Studie

Recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Feb 2018

At a glance

  • Drugs Ketorolac (Primary) ; Triamcinolone (Primary)
  • Indications Retinal oedema
  • Focus Therapeutic Use
  • Acronyms CLOUD
  • Most Recent Events

    • 21 Feb 2018 Planned number of patients changed from 136 to 249.
    • 13 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top